Summit Therapeutics (SMMT) - 2023 Q1 - Earnings Call Transcript

Summit Therapeutics, Inc. (NASDAQ:SMMT) Q1 2023 Earnings Conference Call May 11, 2023 9:00 AM ET Company Participants Dave Gancarz - SVP, Stakeholder Relations, Business Development & Corporate Strategy Robert Duggan - CEO & Executive Chairman Mahkam Zanganeh - Co-CEO, President & Director Ankur Dhingra - CFO Urte Gayko - Head, Regulatory Affairs, Quality Assurance & Safety Conference Call Participants Operator Good morning, and welcome to the Summit Therapeutics First Quarter 2023 Earnings and Update Call. ...